The Development and Evaluation of an "E-Visit" Program for the Management of Acne
NCT ID: NCT00417456
Last Updated: 2012-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
151 participants
INTERVENTIONAL
2005-10-31
2007-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. That an "E-Visit" is an effective alternative to in-person clinic care for patients with mild to severe facial acne.
2. That providers and patients will be satisfied with this model.
3. That mean wait times for new and return visits will be reduced through the "E-Visit" model.
4. That this prototype for care will improve clinic workflow, offer additional patient access, and allow urgent cases to be seen earlier.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone
NCT02031718
The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin
NCT03707236
Teledermatology vs. Face-to-Face Visits in the Follow-Up of Patients With Acne
NCT04593004
A Study to Determine the Efficacy of Topically Applied MTC896 Gel in Subjects With Acne Vulgaris
NCT02395549
Evaluation of a Photopneumatic System for the Treatment of Acne
NCT01257555
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Teledermatology has received much attention as a solution to the preceding problems. Teledermatology can reduce the burden of repeat office visits in chronic conditions by facilitating care from home. In this trial, a model incorporating store-and-forward technology is tested in general clinics while its impact on clinical outcomes, satisfaction, and wait times are studied.
Comparison: After consent, study subjects are assigned a unique study number and randomly assigned to one of two groups:
Group 1- The first group of subjects will have four (4) in-office visits spaced six weeks apart.
Group 2- The second group will have four (4) "e-visits" spaced six weeks apart.
At the end of study (after completion of 5th visit overall) all participants will complete a satisfaction survey.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Office Visits
Office visit
Conventional office-based care
2
Evisit
Evisit
Asynchronous,remote care delivery via a secure web platform
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evisit
Asynchronous,remote care delivery via a secure web platform
Office visit
Conventional office-based care
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of mild to severe facial acne
* Access to a credit card
* Access to an Internet connection and a computer
* Ability to image self
* MA Blue Cross/ Blue Shield Coverage
Exclusion Criteria
* Patients taking Accutane for their acne
* Impaired Physical ability to image self
* Impaired Cognitive ability
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joseph C. Kvedar
Director, Center for Connected Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joseph C. Kvedar, M.D.
Role: PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MGH Dermatology Associates
Boston, Massachusetts, United States
Brigham and Women's Hospital Department of Dermatology
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Watson AJ, Bergman H, Williams CM, Kvedar JC. A randomized trial to evaluate the efficacy of online follow-up visits in the management of acne. Arch Dermatol. 2010 Apr;146(4):406-11. doi: 10.1001/archdermatol.2010.29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2005-P-000289
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.